Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)

NCT02524847 is registered in ClinicalTrials.gov with Therakos, Inc., a Mallinckrodt Company as lead sponsor.

NCT NCT02524847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Arm Study to Assess the Efficacy of UVADEX® (Methoxsalen) Sterile Solution in Conjunction With the THERAKOS® CELLEX® Photopheresis System in Pediatric Patients With Steroid-Refractory Acute Graft-vs-Host Disease (aGvHD)
Lead sponsor
Therakos, Inc., a Mallinckrodt Company
Phase
Phase 3
Overall status
Terminated
Start date
January 20, 2016
Completion date
July 16, 2019
Enrollment
29 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

steroid refractory acute graft versus host disease